Nickie spent over 4 years trying to find the cause of her son, Liam's symptoms. When tests came back confirming MCT8 deficiency, she was devastated but also determined to create the best possible future for her son. To understand the complexities of the disorder including diagnosis and management, we'll hear from Dr. Larry Fox, Chief of Pediatric Endocrinologist and Diabetes at Nemours Children's Health and Dr. Andrew J. Bauer, Director of the Pediatric Thyroid Center at Children's Hospital of Philadelphia (CHOP). Industry and advocacy are pillars of the rare disease community, sharing their unique perspectives, MCT8-AHDS Foundation Board Member, Jennifer Favre and Anny Bedard, President of Egetis Therapeutics North America will be in studio for an exclusive interview. About MCT8 Deficiency: MCT8 deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS), is a debilitating and life-threatening rare genetic disorder that affects a child's cognition, mobility and overall health. This
